Researchers
Đurić, Ana
Results 1-20 of 84
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | The Landscape of Ferroptosis-Related Gene Signatures as Molecular Stratification in Triple-Negative Breast Cancer![]() | Buta, Marko | Article | 21M21 |
| 2026 | Profiling neoadjuvant therapy response in rectal cancer using meta-analysis of publicly available transcriptomic RNA-seq datasets![]() | Stanojevic, Aleksandra | Article | 21M21 |
| 2026 | Integrated in silico and experimental approach to the development of dual HDAC/ROCK inhibitors for the treatment of aggressive malignancies![]() | Beljkaš, Milan | Conference Paper | Mp. category will be shown later |
| 2026 | Effects of nebulized dexmedetomidine for premedication on the parameters of oxidative and inflammatory stress in children undergoing tonsillotomy and adenoidectomy: A pilot randomized controlled trial![]() | Stevanović, Vesna V.; Mandraš, Ana D.; Đurić, Ana A. | Article | 21M21 |
| 2026 | Multi-Target Anticancer Activity of Structurally Diverse Schiff Bases: Insights into Cell-Cycle Arrest, DNA Damage, Metabolic Signaling, and Biomolecular Binding![]() | Joksimović, Nenad | Article | 22M22 |
| 2026 | Prognostic significance of postoperative pathological features after neoadjuvant chemoradiotherapy in locally advanced rectal cancer![]() | Marinković, Mladen | Conference Paper | Mp. category will be shown later |
| 2025 | P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2025 | Novel 1-benzhydryl piperazine scaffoldbased HDAC inhibitor b7 induces synergistic antiproliferative effect with vemurafenib in colorectal cancer cells harboring BRAF mutation![]() | Vuletić, Ana | Conference Paper | Mp. category will be shown later |
| 2025 | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents![]() | Beljkaš, Milan | Article | 22M22 |
| 2025 | Prognostic factors for disease-free interval in patients with rectal cancer treated with neoadjuvant chemoradiotherapy and dose intensification![]() | Marinković Mladen S. | Conference Paper | Mp. category will be shown later |
| 2024 | Analysis of the Chemical and Medicinal Properties of Armillaria ostoyae (Agaricomycetes) Extracts and the Presence of Heavy Metals in Dry Basidiocarps![]() | Petrovic, Nevena N | Article | 23M23 |
| 2024 | Navigating ELSI for FAIR multiomics data management within STEPUPIORS international rectal cancer project![]() | Tanic, Miljana | Conference Paper | Mp. category will be shown later |
| 2024 | Biobanking from Scratch: A Roadmap to Setup a Rectal Cancer Biobank Within the STEPUPIORS Project![]() | Tanic, Miljana | Conference Paper | Mp. category will be shown later |
| 2024 | Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia—Insights from the Institute for Oncology and Radiology of Serbia![]() | Cavic, Milena | Article | 21M21 |
| 2024 | Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia – Insights from the Institute for Oncology and Radiology of Serbia![]() | Cavic, Milena | Other | Mp. category will be shown later |
| 2024 | Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy![]() | Grahovac, Jelena S | Article | 21M21 |
| 2024 | Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Integrative Framework for Developing Innovative SIRT2 Inhibitors![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Abstract 1304: Employing widening funds to address inequity in cancer research - example of the STEPUPIORS collaborative rectal cancer project![]() | Cavic, Milena | Conference Paper | Mp. category will be shown later |
| 2024 | Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design![]() | Beljkaš, Milan | Article | 21aM21a |
